Showing results (1351-1360 of 1,375) with videos related to
Sort By:
Pageof 138
Brain : a Journal of Neurology|April 22, 2026
Machine learning model based on plasma proteomics for the identification of Parkinson's diseaseBoluwatife Adewale, Ruth Chia, Ruin Moaddel, et al.JAMA Neurology|August 30, 2016
Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson DiseaseMarie Y Davis, Catherine O Johnson, James B Leverenz, et al.Journal of the American Heart Association|September 25, 2025
Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP-Ribose) Polymerase Inhibitor VeliparibRaymond C Koehler, Karni Bedirian, Mu-Hsun Chen, et al.Science Translational Medicine|July 29, 2021
PARIS farnesylation prevents neurodegeneration in models of Parkinson's diseaseAreum Jo, Yunjong Lee, Tae-In Kam, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 5, 2015
Cognitive profile of LRRK2-related Parkinson's diseaseSindhu Srivatsal, Brenna Cholerton, James B Leverenz, et al.Science Translational Medicine|August 17, 2018
Finding useful biomarkers for Parkinson's diseaseAlice S Chen-Plotkin, Roger Albin, Roy Alcalay, et al.Neurology|February 10, 2015
PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson diseaseGary W Beecham, Dennis W Dickson, William K Scott, et al.Nature Communications|May 31, 2024
Aplp1 interacts with Lag3 to facilitate transmission of pathologic α-synucleinXiaobo Mao, Hao Gu, Donghoon Kim, et al.Nature Medicine|August 19, 2025
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosisRuth Chia, Ruin Moaddel, Justin Y Kwan, et al.Science Translational Medicine|July 6, 2012
Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's diseaseOliver Cooper, Hyemyung Seo, Shaida Andrabi, et al.Pageof 138